Crossmark

Statins and immune checkpoint inhibitors: a strategy to improve the efficacy of immunotherapy for cancer?

Crossref DOI link: https://doi.org/10.1136/jitc-2022-005611

Published Online: 2022-09-02

Published Print: 2022-09

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Vos, Winnie G https://orcid.org/0000-0001-7805-7275
Lutgens, Esther

Seijkens, Tom T P
Funding

Funding for this research was provided by:

Amsterdam Cardiovascular Sciences (N/A)

Heart Foundation (N/A)
License Information

License valid from 2022-09-02